PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Drugs for low libido raise concerns over industry 'construction' of new diseases

Feature: Merging of marketing and medical science: female sexual dysfunction

2010-10-01
(Press-News.org) Drug companies have not only sponsored the science of a new condition known as female sexual dysfunction, they have helped to construct it, in order to build global markets for new drugs, reveals an article in this week's BMJ.

Researching his new book 'Sex, Lies and Pharmaceuticals' Ray Moynihan, journalist and lecturer at the University of Newcastle in Australia, discovered that drug industry employees have worked with paid key opinion leaders to help develop the disease entity; they have run surveys to portray it as widespread; and they helped design diagnostic tools to persuade women that their sexual difficulties deserve a medical label and treatment.

He believes that "drug marketing is merging with medical science in a fascinating and frightening way" and he asks whether we need a fresh approach to defining disease.

He quotes a company employee saying that her company was interested in "expediting the development of a disease" and he reveals how companies are funding surveys that portray sexual problems as widespread and creating tools to assess women for "hypoactive sexual desire disorder."

Many of the researchers involved in these activities were drug company employees or had financial ties to the industry, writes Moynihan. Meanwhile, scientific studies conducted without industry funding were questioning whether a widespread disorder of low desire really existed.

Industry is also taking a leading role in "educating" both professionals and the public about this controversial condition, he adds.

For example, a Pfizer funded course designed for doctors across the United States claimed that up to 63% of women had sexual dysfunction and that testosterone and sildenafil (Viagra) may be helpful, along with behavioural therapy. And he points out that German drug company Boehringer Ingelheim's "educational" activities "went into overdrive" as the planned 2010 launch of its desire drug, flibanserin, approached.

In June, flibanserin was rejected by advisors to the US Food and Drug Administration and Pfizer's sildenafil was also pulled after studies showed virtually no difference from placebo. But although the drugs have so far failed, Moynihan warns that "the edifice of scientific evidence about the condition remains in place … creating the impression that there is a massive "unmet need" for treatment."

And with more experimental drugs in the pipeline, "the drug industry shows no signs of abandoning plans to meet the unmet need it has helped to manufacturer," he says.

"Perhaps it's time to reassess the way in which the medical establishment defines common conditions and recommends how to treat them," he suggests.

"Perhaps it is time to develop new panels to take responsibility for defining treatable illness, made up of people without financial ties to those with vested interests in the outcomes of their deliberations and much more broadly representative of the wider public … and start the slow process of untangling the marketing from the medical science." he concludes.

"Faced with a woman in tears whose libido has disappeared and who is terrified of losing her partner, doctors can feel immense pressure to provide an immediate, effective solution," says Dr Sandy Goldbeck-Wood, a specialist in psychosexual medicine, in an accompanying commentary.

She says Moynihan's research clarifies both the conflicts of interest at work and the relative paucity of good quality evidence for pharmacological solutions to women's sexual problems. However, she argues: "his argument that female sexual dysfunction is an illness constructed by pathologising doctors under the influence of drug companies will fail to convince clinicians who see women with sexual dysfunction, or their patients."

Women who have struggled to overcome the psychological and cultural barriers to requesting help with their sexual difficulties will not welcome the argument that they are to be "left alone," she writes.

She believes the problem is one of oversimplification and believes that more studies are needed that reflect the complexity of sexual life. "It's time to invest in more research into the most realistic, respectful and evidence based treatments, rather than narrow biological ones founded on poor evidence," she says.

INFORMATION: The BMJ is hosting an event in London on 4 October 2010 about female sexual dysfunction and the pharmaceutical industry.

Click here for more information: http://resources.bmj.com/bmj/about-bmj/bmj-spotlight-on-female-sexual-dysfunction

Journalists wishing to attend should contact Emma Dickinson on +44 (0)20 7383 6529.



ELSE PRESS RELEASES FROM THIS DATE:

Should athletes undergo mandatory ECG screening?

2010-10-01
Should athletes have to undergo mandatory electrocardiographic screening (also known as ECG or heart trace) before competing? Doctors debate the issue in this week's BMJ. Antonio Pelliccia and Domenico Corrado argue that screening athletes for "silent" heart problems would save lives. They say the best evidence of the efficacy of ECG screening on mortality in athletes comes from Italy, the only country where it is required by law, and where a mass screening programme has been in place for almost 30 years. The incidence of sudden deaths before and after implementation ...

Virginia Tech professor discovers new TB pathogen

Virginia Tech professor discovers new TB pathogen
2010-10-01
Kathleen Alexander, associate professor of wildlife in Virginia Tech's College of Natural Resources and Environment, has discovered a novel tuberculosis (TB) species in the Mycobacterium tuberculosis complex, a group of pathogens that have adapted by using mammals as hosts. It has been nearly two decades since a new organism was identified in this group; the majority were discovered in the early and mid 20th century. Tuberculosis is presently the leading cause of death from infectious disease, infecting more than a third of the world's population. Alexander discovered ...

RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors

2010-10-01
Therapeutic lentiviral vectors are emerging as vital tools for molecular medicine as evidenced by the growing number of clinical trials using these vector systems. From a basic research standpoint, lentiviral vectors are very intriguing substrates. On the one hand, the HIV-1 genome offers expanded cloning capacity and the capability to transduce nondividing cells such as hematopoietic stem cells (HSCs) and neurons. However, concerns associated with the potential risk of generating replication competent lentiviral particles require the removal of significant portions ...

Knot in the ribbon at the edge of the solar system 'unties'

2010-10-01
The unusual "knot" in the bright, narrow ribbon of neutral atoms emanating in from the boundary between our solar system and interstellar space appears to have "untied," according to a paper published online in the Journal of Geophysical Research. Researchers believe the ribbon, first revealed in maps produced by NASA's Interstellar Boundary Explorer (IBEX) spacecraft, forms in response to interactions between interstellar space and the heliosphere, the protective bubble in which the Earth and other planets reside. Sensitive neutral atom detectors aboard IBEX produce ...

Black aspergilli species responsible for infecting corn identified

2010-10-01
U.S. Department of Agriculture (USDA) scientists in Athens, Georgia, have reported for the first time that several species of Aspergillus niger, or black aspergilli, are capable of infecting corn and peanuts as endophytes. The researchers also showed that, under laboratory conditions, these species produced mycotoxins. Using a molecular procedure they developed, USDA Agricultural Research Service (ARS) research leader Charles Bacon, microbiologist Dorothy Hinton, and Edwin Palencia, a graduate student in the Department of Plant Pathology of the University of Georgia in ...

K-State research finds that educators should encourage college students to shoot for the stars

2010-10-01
MANHATTAN, KAN. -- Less academically promising students should not be discouraged from setting high educational goals, according to one Kansas State University professor's research. Chardie Baird, K-State assistant professor of sociology, and John Reynolds, Florida State University professor of sociology, looked at the mental health consequences of shooting for the stars versus planning for the probable in their publication "Is There a Downside to Shooting for the Stars? Unrealized Educational Expectations and Symptoms of Depression." Their research, published earlier ...

Bioethics scholars fault requirement that all women in clinical drug trials use contraception

2010-10-01
(Garrison, NY) Research ethics review committees often require all women of childbearing age who enroll in clinical trials to use contraceptives to protect against a developing fetus being exposed to potentially harmful drugs. A mandatory contraceptive policy is often imposed even when there is no evidence that a trial drug could harm a fetus or when women have no chance of becoming pregnancy. This requirement is excessive and can safely be relaxed in many cases, according to a report in IRB: Ethics & Human Research. Policies on contraceptive use in research should reflect ...

Researchers at the University of Granada associate trigger points with shoulder injury

Researchers at the University of Granada associate trigger points with shoulder injury
2010-10-01
Researchers of the University of Granada, in collaboration with the Centre for Sensory-Motor Interaction of the University of Aalborg, Denmark, and the University Rey Juan Carlos, Madrid, conducted a research on chronic impingement syndrome. The study revealed that excessive activation of specific neck and shoulder muscles during daily life or while playing sports –as swimming– is the cause of a high number of injury and shoulder A Common Pain The pattern of the pain originated in these muscles –sometimes in regions far from the shoulder– coincides with most of the symptoms ...

Hydrogen fuel for thought

2010-10-01
New research by Rice University scientists suggests that a class of material known as metallacarborane could store hydrogen at or better than benchmarks set by the United States Department of Energy (DOE) Hydrogen Program for 2015. The work could receive wide attention as hydrogen comes into play as a fuel of the future for cars, in fuel cells and by industry. The new study by Rice theoretical physicist Boris Yakobson and his colleagues, which appears in the online Journal of the American Chemical Society, taps the power of transition metals scandium and titanium to ...

URI professor warns: TV viewing likely to make you fear sickness

2010-10-01
KINGSTON, R.I.-– September 30, 2010 –Watching television and its heavy dose of medical content in news and drama can lead to more concern about personal health and reduce a person's satisfaction with life according to a new study out of the University of Rhode Island. The study, authored by Yinjiao Ye, assistant professor of communications studies found that TV viewing affects people's awareness of health-risks and whether they believe they can protect their own health. People develop these perceptions because TV viewing leads them to believe they have a greater likelihood ...

LAST 30 PRESS RELEASES:

Laser solid-phase synthesis of graphene shell-encapsulated high-entropy alloy nanoparticles

New catalyst breakthrough: Improving oxygen reduction reaction with dual nitrogen sources

Protein shakeup: Researchers uncover new function of a protein that may unlock age-related illnesses

UMD-led study could ‘pave the way’ for improved treatment of premature aging disease

How chain IVF clinics improve infertility treatment

Study shows that Rett syndrome in females is not just less severe, but different

Big data, real world, multi-state study finds RSV vaccine highly effective in protecting older adults against severe disease, hospitalization and death

Manliness concerns impede forgiveness of coworkers

Better ocean connectivity boosts reef fish populations

Two 2024 Nobel laureates are affiliates of the Marine Biological Laboratory, Woods Hole

Ultra-processed foods pose unique dangers for people with type 2 diabetes

When hurricanes hit, online chatter drowns out safety messaging

Study seeks rapid, paper-based test to detect cancer cells in cerebrospinal fluid

Raising happy eaters: Unlocking the secrets of childhood appetite

The Society of Thoracic Surgeons launches two new thoracic surgery risk calculators

FAPESP and CNR plan to launch joint call for proposals in April 2025

Smaller, more specific academic journals have more sway over policy

Medicaid ACOs have not yet improved care for kids with asthma

New study sheds light on lily toxicity in cats; outpatient treatment may be viable option

A new benchmark to recognize the hardest problems in materials science

Why do we love carbs? The origins predate agriculture and maybe even our split from Neanderthals

Key protein for the biosynthesis of defense steroids in solanaceous plants discovered

Global CO2 emissions from forest fires increase by 60%

AI-assisted deliberation can help people with different views find common ground

Special Issue explores factors influencing democratic attitudes, and what’s at stake for science in the U.S. after November election

Extratropical forest fire emissions are increasing as climate changes

A new approach to capturing complex mixtures of organic chemicals in blood, evaluated in pregnant women

Gut instincts: Intestinal nutrient sensors

Catching prey with grappling hooks and cannons

Effects of chemical mixtures: Neurotoxic effects add up

[Press-News.org] Drugs for low libido raise concerns over industry 'construction' of new diseases
Feature: Merging of marketing and medical science: female sexual dysfunction